Paid Clinical Trials in McAllen, TX
As of September 2026, 72 paid clinical trials are recruiting in McAllen, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
McAllen offers studies at sites including Biopharma Informatic, LLC for conditions such as Diabetic Foot Ulcer, Heart Failure, Breast Cancer, Breast Neoplasms. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in McAllen
Trials by drug in McAllen
Filter results
Newly added in McAllen
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)
70 clinical trials
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Top Research Study Locations in McAllen
Researchers run research studies in McAllen, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Biopharma Informatic, LLC | Irritable Bowel Syndrome, Atherosclerotic Cardiovascular Disease (ASCVD), Constipation | 6 |
| Valley Retina Institute | Dry Age-related Macular Degeneration, AMD, Age-Related Macular Degeneration | 5 |
| Futuro Clinical Trials | Diabetic Foot Ulcer, Chronic Wound, Knee Cartilage Defects | 4 |
| Texas Oncology - Central South | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, Renal Cell | 3 |
| Valley Retina Institute, P.A. | Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD), Age-related Macular Degeneration (AMD) | 3 |
| Vannie Cook Children's Clinic | Adrenal Gland Pheochromocytoma, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | 3 |
| Texas Oncology - Central/South Texas | Advanced Non-Small Cell Lung Cancer, Advanced/Metastatic Urothelial Cancer, Carcinoma, Non-Small-Cell Lung | 3 |
| A & A Research Consultants, LLC | Interstitial Lung Disease, Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis | 2 |
| Biopharma Informatic LLC | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| Centex Studies, Inc. | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| Gamma Medical Research | Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis, Chronic Kidney Disease, Receiving Dialysis | 2 |
| Nova Oncology | Neoplasm Metastasis, Breast Neoplasms, Carcinoma, Transitional Cell | 2 |
| Valley Retina Institute, PA | Diabetic Macular Edema, Neovascular (Wet) Age-Related Macular Degeneration | 2 |
| ADARx Clinical Site | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Akero Clinical Study Site | MASH With Fibrosis, NASH With Fibrosis | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Biopharma Informatic - Ridge Road - PPDS | Sjögren's Syndrome | 1 |
| Biopharma Informatic-McAllen | Atherosclerotic Cardiovascular Disease, Obesity, Overweight | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| DCT-McAllen Primary Care Research, LLC | Respiratory Syncytial Virus Infections | 1 |
| DCT-McAllen Primary Care Research, LLC dba Discovery Clinical Trials | Migraine | 1 |
| DHR Health Headache Center | Migraine | 1 |
| DHR Health Institute for Research | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 1 |
| DHR Health Institute for Research and Development | Hepatocellular Carcinoma | 1 |
Active & Upcoming Studies in McAllen (2026)
Recruiting trials in McAllen grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (13 active studies)
- Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer · Phase 1, Phase 2 · Pfizer
- Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer · Phase 1, Phase 2 · Pfizer
Eye & vision (13 active studies)
Cardiovascular (6 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Diabetes & metabolic (4 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes · Phase 3 · Hoffmann-La Roche
Vaccines (2 active studies)
- A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease · Phase 2 · Shionogi
- A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients · DiaSorin Molecular LLC
Neurology & pain (2 active studies)
Common conditions studied in McAllen
- Diabetic Foot Ulcer (3 active studies)
- Heart Failure (3 active studies)
- Breast Cancer (2 active studies)
- Breast Neoplasms (2 active studies)
- Dry Age-related Macular Degeneration (2 active studies)
- Geographic Atrophy (GA) (2 active studies)
Leading research sponsors in McAllen
- Pfizer
- Eli Lilly and Company
- AstraZeneca
- Boehringer Ingelheim
- Regeneron Pharmaceuticals
Frequently asked questions
How many paid clinical trials are currently recruiting in McAllen?
There are approximately 72 recruiting clinical trials in McAllen, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in McAllen pay participants?
Most recruiting trials in McAllen compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in McAllen?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in McAllen?
The most common conditions under active study in McAllen include Diabetic Foot Ulcer (3), Heart Failure (3), Breast Cancer (2), Breast Neoplasms (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in McAllen?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in McAllen on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in McAllen?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in McAllen?
Recruiting research sites in McAllen include Biopharma Informatic, LLC, Valley Retina Institute, Futuro Clinical Trials, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in McAllen right now?
The largest active categories in McAllen are Cancer & tumors (13), Eye & vision (13), Cardiovascular (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.